ArticleFrontiers in medicine2022
A Few-Shot Learning-Based Retinal Vessel Segmentation Method for Assisting in the Central Serous Chorioretinopathy Laser Surgery.
Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A comprehensive overview: deep learning approaches to central serous chorioretinopathy diagnosis.BMC ophthalmology · 2025Pooled it
- Radiomics-based fundus autofluorescence analysis in central serous chorioretinopathy-MICRoN report number twelve.Scientific reports · 2026Article
- The impact of preoperative inflammatory indices on retinal vessel density and macular perfusion after anti-VEGF treatment in branch retinal vein occlusion (BRVO) using wide-field SS-OCTA.Frontiers in medicine · 2026Article
- Artificial Intelligence Applications in Sickle Cell Retinopathy Imaging: Current Progress, Challenges, and Future Directions.Journal of ophthalmology · 2026Review
- Research Progress in Artificial Intelligence for Central Serous Chorioretinopathy: A Systematic Review.Ophthalmology and therapy · 2025Review
- MSLI-Net: retinal disease detection network based on multi-segment localization and multi-scale interaction.Frontiers in cell and developmental biology · 2025Article
- Intravitreal conbercept for chronic central serous chorioretinopathy with occult CNV: a retrospective clinical study based on multimodal ophthalmic imaging.Frontiers in medicine · 2025Article
- Artificial intelligence in chorioretinal pathology through fundoscopy: a comprehensive review.International journal of retina and vitreous · 2024Review
- Systematic bibliometric and visualized analysis of research hotspots and trends on the application of artificial intelligence in glaucoma from 2013 to 2022.International journal of ophthalmology · 2024Article
- Systematic Bibliometric and Visualized Analysis of Research Hotspots and Trends on the Application of Artificial Intelligence in Ophthalmic Disease Diagnosis.Frontiers in pharmacology · 2022Article
- Hypermixed Convolutional Neural Network for Retinal Vein Occlusion Classification.Disease markers · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The location of retinal vessels is an important prerequisite for Central Serous Chorioretinopathy (CSC) Laser Surgery, which does not only assist the ophthalmologist in marking the location of the leakage point (LP) on the fundus color image but also avoids the damage of the laser spot to the vessel tissue, as well as the low efficiency of the surgery caused by the absorption of laser energy by retinal vessels. In acquiring an excellent intra- and cross-domain adaptability, the existing deep learning (DL)-based vessel segmentation scheme must be driven by big data, which makes the densely annotated work tedious and costly. Methods: This paper aims to explore a new vessel segmentation method with a few samples and annotations to alleviate the above problems. Firstly, a key solution is presented to transform the vessel segmentation scene into the few-shot learning task, which lays a foundation for the vessel segmentation task with a few samples and annotations. Then, we improve the existing few-shot learning framework as our baseline model to adapt to the vessel segmentation scenario. Next, the baseline model is upgraded from the following three aspects: (1) A multi-scale class prototype extraction technique is designed to obtain more sufficient vessel features for better utilizing the information from the support images; (2) The multi-scale vessel features of the query images, inferred by the support image class prototype information, are gradually fused to provide more effective guidance for the vessel extraction tasks; and (3) A multi-scale attention module is proposed to promote the consideration of the global information in the upgraded model to assist vessel localization. Concurrently, the integrated framework is further conceived to appropriately alleviate the low performance of a single model in the cross-domain vessel segmentation scene, enabling to boost the domain adaptabilities of both the baseline and the upgraded models. Results: Extensive experiments showed that the upgraded operation could further improve the performance of vessel segmentation significantly. Compared with the listed methods, both the baseline and the upgraded models achieved competitive results on the three public retinal image datasets (i.e., CHASE_DB, DRIVE, and STARE). In the practical application of private CSC datasets, the integrated scheme partially enhanced the domain adaptabilities of the two proposed models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.